(Q45006572)

8 December 2017

Experience with azathioprine in systemic sclerosis associated with interstitial lung disease (English)

1 reference

8 December 2017

0 references

K Dheda

1

1 reference

8 December 2017

U G Lalloo

series ordinal

2

1 reference

8 December 2017

B Cassim

series ordinal

3

1 reference

8 December 2017

G M Mody

series ordinal

4

1 reference

8 December 2017

14 April 2004

1 reference

8 December 2017

Clinical Rheumatology

1 reference

8 December 2017

23

1 reference

8 December 2017

4

1 reference

8 December 2017

306-309

1 reference

Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy

8 December 2017

1 reference

12 December 2020

Treatment of systemic lupus erythematosus

1 reference

12 December 2020

Therapy for severe interstitial lung disease in systemic sclerosis. A retrospective study

1 reference

12 December 2020

Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with idiopathic pulmonary fibrosis.

1 reference

12 December 2020

Intravenous cyclophosphamide pulse therapy for the treatment of lung disease associated with scleroderma

1 reference

12 December 2020

6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity

1 reference

12 December 2020

A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis

1 reference

12 December 2020

Visceral improvement following combined plasmapheresis and immunosuppressive drug therapy in progressive systemic sclerosis

1 reference

12 December 2020

Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide

1 reference

12 December 2020

Cyclophosphamide in the treatment of idiopathic pulmonary fibrosis: a prospective study in patients who failed to respond to corticosteroids

1 reference

12 December 2020

The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes

1 reference

12 December 2020

Intravenous pulse cyclophosphamide in the treatment of interstitial lung disease due to collagen vascular diseases

1 reference

12 December 2020

Azathioprine Combined with Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis: A Prospective Double-blind, Randomized, Placebo-controlled Clinical Trial

1 reference

12 December 2020

Immunosuppressive drug therapy of systemic lupus erythematosus.

1 reference

12 December 2020

Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis

1 reference

12 December 2020

Immunosuppressive drug therapy

1 reference

12 December 2020

A pilot study of intermittent intravenous cyclophosphamide for the treatment of systemic sclerosis associated lung disease

1 reference

12 December 2020

The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction

1 reference

12 December 2020

D-penicillamine therapy and interstitial lung disease in scleroderma. A long-term followup study

1 reference

12 December 2020

Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis.

1 reference

12 December 2020

10.1007/S10067-004-0906-7

Identifiers

DOI

1 reference

8 December 2017

1 reference